Latest Sales Growth News

CONNEQT Health reported a $2.6 million operating cash outflow in the September quarter but secured $2 million through a convertible note, while expecting a $1.6 million R&D tax refund to shore up liquidity.

CurveBeam AI reports a 33% increase in Q1 FY26 purchase orders, secures A$6.5 million in new funding, and finalizes a strategic joint venture for China distribution and manufacturing rights.

Universal Store Holdings has reported robust FY25 results with revenue climbing 15.5% to $333.3 million and a dividend increase, signaling confidence despite retail headwinds. Early FY26 trading shows continued momentum.

Universal Store Holdings reports a robust 13.7% rise in direct-to-customer sales for FY26 YTD, driven by strong brand performances and a strategic store rollout plan.

TZ Limited reports steady sales growth and new Microsoft contracts in Q1 FY2026, reaffirming its $17–21 million revenue guidance amid improving market conditions.

Coles Group reported a solid 3.9% rise in first quarter sales for FY26, driven by strong supermarket growth and digital expansion, while liquor sales faced ongoing market challenges.

Ampol Limited reported a robust third quarter in 2025 with refinery margins hitting a notable high, offsetting volume declines and setting the stage for strategic growth.

JB Hi-Fi Limited reported robust FY25 results with double-digit sales growth and a leadership transition, while outlining ambitious plans for FY26 focused on expansion and sustainability.

OMG Group Limited reported a robust 56% year-on-year increase in quarterly cash receipts, driven by expanded product distribution and a strategic $2 million capital raise. The company is poised for further growth with new retail partnerships and a high-profile marketing campaign ahead of the summer sales season.

JB Hi-Fi reports solid Q1 FY26 sales growth, led by a remarkable 39.3% increase in New Zealand, while Australian sales maintain steady momentum. The Good Guys and e&s show modest gains as the group prepares for a critical Q2.

ImpediMed Limited reported a record A$3.6 million quarterly revenue and expanded its US hospital footprint with over 600 SOZO units installed. The launch of SOZO Pro targets new heart failure markets, while reimbursement coverage accelerates across US states.

Next Science reported a 3% rise in Q3 product sales and completed a $50 million asset sale to OSARTIS GmbH, setting the stage for a significant shareholder return.